JP2025505652A5 - - Google Patents
Info
- Publication number
- JP2025505652A5 JP2025505652A5 JP2024546456A JP2024546456A JP2025505652A5 JP 2025505652 A5 JP2025505652 A5 JP 2025505652A5 JP 2024546456 A JP2024546456 A JP 2024546456A JP 2024546456 A JP2024546456 A JP 2024546456A JP 2025505652 A5 JP2025505652 A5 JP 2025505652A5
- Authority
- JP
- Japan
- Prior art keywords
- cycles
- combination drug
- antibody
- approximately
- drug according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263307533P | 2022-02-07 | 2022-02-07 | |
| US63/307,533 | 2022-02-07 | ||
| US202263333597P | 2022-04-22 | 2022-04-22 | |
| US63/333,597 | 2022-04-22 | ||
| PCT/CA2023/050151 WO2023147673A1 (en) | 2022-02-07 | 2023-02-06 | Combination therapy for use in treatment of non-small cell lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505652A JP2025505652A (ja) | 2025-02-28 |
| JP2025505652A5 true JP2025505652A5 (https=) | 2026-02-13 |
Family
ID=87553087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546456A Pending JP2025505652A (ja) | 2022-02-07 | 2023-02-06 | 非小細胞肺がんの治療における使用のための併用療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250108110A1 (https=) |
| EP (1) | EP4475885A4 (https=) |
| JP (1) | JP2025505652A (https=) |
| KR (1) | KR20240153627A (https=) |
| AU (1) | AU2023216333A1 (https=) |
| CA (1) | CA3243096A1 (https=) |
| IL (1) | IL314600A (https=) |
| MX (1) | MX2024009671A (https=) |
| WO (1) | WO2023147673A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA034462B1 (ru) * | 2009-11-24 | 2020-02-11 | Алетиа Байотерапьютикс Инк. | Антикластериновые антитела и антигенсвязывающие фрагменты и их использование для уменьшения объема новообразований |
| US9822170B2 (en) * | 2012-02-22 | 2017-11-21 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer |
| CA3173786A1 (en) * | 2021-04-27 | 2022-10-27 | Mario Filion | Method for allowing immune cells infiltration in tumors |
-
2023
- 2023-02-06 MX MX2024009671A patent/MX2024009671A/es unknown
- 2023-02-06 CA CA3243096A patent/CA3243096A1/en active Pending
- 2023-02-06 EP EP23749327.5A patent/EP4475885A4/en active Pending
- 2023-02-06 AU AU2023216333A patent/AU2023216333A1/en active Pending
- 2023-02-06 IL IL314600A patent/IL314600A/en unknown
- 2023-02-06 JP JP2024546456A patent/JP2025505652A/ja active Pending
- 2023-02-06 US US18/729,922 patent/US20250108110A1/en active Pending
- 2023-02-06 WO PCT/CA2023/050151 patent/WO2023147673A1/en not_active Ceased
- 2023-02-06 KR KR1020247029988A patent/KR20240153627A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ten Tije et al. | Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial | |
| JP2022531408A5 (https=) | ||
| JP2023533937A5 (https=) | ||
| TWI719765B (zh) | 使用包含akt抑制劑、紫杉烷及pd-l1抑制劑之組合療法之乳癌治療 | |
| Saif et al. | Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature | |
| JP2021530502A5 (https=) | ||
| JP2022548978A5 (https=) | ||
| Liu et al. | Effect of prior thoracic radiotherapy on prognosis in relapsed small cell lung cancer patients treated with anlotinib: a subgroup analysis of the ALTER 1202 trial | |
| JP2024521105A5 (https=) | ||
| CN109806393B (zh) | 抗pd-1抗体、培美曲塞和铂类药物联合治疗非小细胞肺癌的用途 | |
| JP2021523096A5 (https=) | ||
| JP2021529777A5 (https=) | ||
| JP2021531330A (ja) | 組合せ療法を使用してがんを治療する方法 | |
| JP2025505652A5 (https=) | ||
| CN114159557A (zh) | 一种治疗肿瘤疾病的联合用药组合物及应用 | |
| JP2022530599A5 (https=) | ||
| US20260077040A1 (en) | Compositions and methods for treating advanced solid tumors | |
| JP2022547061A5 (https=) | ||
| CN103338779B (zh) | 分枝杆菌w在制备治疗癌症药物中的用途 | |
| JP2023534300A5 (https=) | ||
| CN110013552B (zh) | 抗pd-1抗体、吉西他滨和铂类药物联合治疗恶性胆道肿瘤的用途 | |
| JP2024511977A5 (https=) | ||
| Chen et al. | Re-irradiation with concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck | |
| Trédaniel et al. | Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer | |
| US20250019441A1 (en) | Treatment of cancer with anti-ilt2 antibodies |